Search Results

Filter
  • 1-10 of  5,341 results for ""Dose-Response Relationship, Drug""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Subgroup-specific dose finding for phase I-II trials using Bayesian clustering.

  • Authors : Curtis A; Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA.; Department of Statistics, Data and Analytics, Eli Lilly and Company, Indianapolis, Indiana, USA.

Subjects: Dose-Response Relationship, Drug* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Bayes Theorem

  • Source: Statistics in medicine [Stat Med] 2022 Jul 20; Vol. 41 (16), pp. 3164-3179. Date of Electronic Publication: 2022 Apr 16.Publisher: Wiley Country of Publication: England NLM ID: 8215016 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0258

Record details

×
Academic Journal

Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer.

  • Authors : Brock K; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK. .; Homer V

Subjects: Dose-Response Relationship, Drug* ; Maximum Tolerated Dose*; Neoplasms/Neoplasms/Neoplasms/*drug therapy

  • Source: BMC cancer [BMC Cancer] 2021 Jul 05; Vol. 21 (1), pp. 777. Date of Electronic Publication: 2021 Jul 05.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

A regularized functional regression model enabling transcriptome-wide dosage-dependent association study of cancer drug response.

  • Authors : Koukouli E; Department of Mathematics and Statistics, Fylde College, Lancaster University, Bailrigg, Lancaster, UK.; Wang D

Subjects: Dose-Response Relationship, Drug* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/genetics

  • Source: PLoS computational biology [PLoS Comput Biol] 2021 Jan 25; Vol. 17 (1), pp. e1008066. Date of Electronic Publication: 2021 Jan 25 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

A mixed therapy minimal model: Some strategies for eradication or minimization of cancer.

  • Authors : Younus Baba M; Research Scholar Department of Applied Mathematics, Aligarh Muslim University, Aligarh, Uttar Pradesh, India 202002. Electronic address: .; Saleem M

Subjects: Dose-Response Relationship, Drug*; Cell Physiological Phenomena/Cell Physiological Phenomena/Cell Physiological Phenomena/*drug effects ; Neoplasms/Neoplasms/Neoplasms/*drug therapy

  • Source: Computer methods and programs in biomedicine [Comput Methods Programs Biomed] 2020 Aug; Vol. 192, pp. 105433. Date of Electronic Publication: 2020 Mar 03.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8506513 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

The combined effect of optimal control and swarm intelligence on optimization of cancer chemotherapy.

  • Authors : Shindi O; Department of Electrical Engineering, Faculty of Engineering, University of Malaya, 50603, Kuala Lumpur, Malaysia.; Kanesan J

Subjects: Algorithms* ; Dose-Response Relationship, Drug*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage

  • Source: Computer methods and programs in biomedicine [Comput Methods Programs Biomed] 2020 Jun; Vol. 189, pp. 105327. Date of Electronic Publication: 2020 Jan 09.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8506513 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Relationship Between Response and Dose in Published, Contemporary Phase I Oncology Trials.

Subjects: Clinical Trials, Phase I as Topic* ; Dose-Response Relationship, Drug*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage

  • Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2020 Apr; Vol. 18 (4), pp. 428-433.Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A latent variable model for improving inference in trials assessing the effect of dose on toxicity and composite efficacy endpoints.

  • Authors : Wason JM; Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.

Subjects: Dose-Response Relationship, Drug*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*toxicity

  • Source: Statistical methods in medical research [Stat Methods Med Res] 2020 Jan; Vol. 29 (1), pp. 230-242. Date of Electronic Publication: 2019 Feb 25.Publisher: SAGE Publications Country of Publication: England NLM ID: 9212457 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Phase I Study to Evaluate the Safety of the Herbal Medicine SH003 in Patients With Solid Cancer.

  • Authors : Cheon C; Department of Korean Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.; Ko SG

Subjects: Dose-Response Relationship, Drug* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/pathology

  • Source: Integrative cancer therapies [Integr Cancer Ther] 2020 Jan-Dec; Vol. 19, pp. 1534735420911442.Publisher: Sage Publications Country of Publication: United States NLM ID: 101128834 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Reprioritizing Risk and Benefit: The Future of Study Design in Early-Phase Cancer Research.

  • Authors : Sisk BA; Clinical fellow in pediatric hematology/oncology in the Department of Pediatrics at Washington University School of Medicine.; Dubois J

Subjects: Dose-Response Relationship, Drug* ; Maximum Tolerated Dose* ; Research Design*

  • Source: Ethics & human research [Ethics Hum Res] 2019 Nov; Vol. 41 (6), pp. 2-11.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101738005 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Dose-finding designs for cumulative toxicities using multiple constraints.

  • Authors : Lee SM; Department of Biostatistics, Mailman School of Public Health, Columbia University, 722 W. 168th St, New York, NY, USA.; Ursino M

Subjects: Clinical Trials as Topic* ; Dose-Response Relationship, Drug* ; Models, Statistical*

  • Source: Biostatistics (Oxford, England) [Biostatistics] 2019 Jan 01; Vol. 20 (1), pp. 17-29.Publisher: Oxford University Press Country of Publication: England NLM ID: 100897327 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  5,341 results for ""Dose-Response Relationship, Drug""